COMMUNIQUÉ DE PRESSE publié le 01/12/2023 à 13:00, il y a 2 années 6 mois HanchorBio to Present at the ESMO Immuno-Oncology 2023 Annual Congress HanchorBio Inc. announces poster presentation at ESMO-IO 2023 Annual Congress, featuring innovative immuno-biomedicines targeting solid tumors and hematological malignancies HanchorBio Inc. ESMO-IO 2023 Immuno-biomedicines Solid Tumors Hematological Malignancies
COMMUNIQUÉ DE PRESSE publié le 03/10/2023 à 13:30, il y a 2 années 8 mois HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101
COMMUNIQUÉ DE PRESSE publié le 28/08/2023 à 13:30, il y a 2 années 9 mois HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
COMMUNIQUÉ DE PRESSE publié le 24/07/2023 à 13:30, il y a 2 années 11 mois HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
COMMUNIQUÉ DE PRESSE publié le 17/04/2023 à 13:30, il y a 3 années 2 mois HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
Publié le 26/06/2026 à 17:45, il y a 13 heures 51 minutes Descriptif du programme de rachat d'actions
Publié le 27/06/2026 à 01:40, il y a 5 heures 56 minutes Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Publié le 27/06/2026 à 00:00, il y a 7 heures 36 minutes Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Publié le 26/06/2026 à 23:00, il y a 8 heures 36 minutes Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 8 heures 46 minutes Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 26/06/2026 à 22:15, il y a 9 heures 21 minutes Revive Therapeutics Announces Proposed Private Placement
Publié le 27/06/2026 à 00:05, il y a 7 heures 30 minutes EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Publié le 27/06/2026 à 00:04, il y a 7 heures 31 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 8 heures Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 8 heures EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 8 heures 8 minutes EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
